- Home
- RGC vs MRCC Comparison
RGC vs MRCC Comparison
Compare RGC & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RGC | MRCC |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 151.2M |
| IPO Year | 2021 | 2012 |
Fundamental Metrics
Financial Performance| Metric | RGC | MRCC |
|---|---|---|
| Price | $17.59 | $6.71 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | ★ 210.3K | 102.5K |
| Earning Date | 10-24-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 15.02% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $43,742,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.09 | $5.86 |
| 52 Week High | $83.60 | $8.85 |
Technical Indicators
Market Signals| Indicator | RGC | MRCC |
|---|---|---|
| Relative Strength Index (RSI) | 64.34 | 55.06 |
| Support Level | $16.10 | $6.65 |
| Resistance Level | $17.40 | $6.80 |
| Average True Range (ATR) | 1.62 | 0.14 |
| MACD | 0.63 | 0.06 |
| Stochastic Oscillator | 88.24 | 81.30 |
Price Performance
Historical ComparisonAbout RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
About MRCC Monroe Capital Corporation
Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.